392 related articles for article (PubMed ID: 19788674)
1. Irido-cilio-choroidal melanoma in a 5-year-old boy treated by Ru-106 brachytherapy.
Pe'er J; Averbukh E; Frenkel S
Clin Exp Ophthalmol; 2009 Sep; 37(7):742-3. PubMed ID: 19788674
[No Abstract] [Full Text] [Related]
2. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
[TBL] [Abstract][Full Text] [Related]
3. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound biomicroscopy features of iris and ciliary body melanomas before and after brachytherapy.
Torres VL; Allemann N; Erwenne CM
Ophthalmic Surg Lasers Imaging; 2005; 36(2):129-38. PubMed ID: 15792314
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium-106 Plaque Brachytherapy in the Primary Management of Ocular Medulloepithelioma.
Poon DS; Reich E; Smith VM; Kingston J; Reddy MA; Hungerford JL; Sagoo MS
Ophthalmology; 2015 Sep; 122(9):1949-51. PubMed ID: 25863421
[No Abstract] [Full Text] [Related]
6. Ruthenium-106 brachytherapy for iris and iridociliary melanomas.
Marinkovic M; Horeweg N; Laman MS; Bleeker JC; Ketelaars M; Peters FP; Luyten GPM; Creutzberg CL
Br J Ophthalmol; 2018 Aug; 102(8):1154-1159. PubMed ID: 29122824
[TBL] [Abstract][Full Text] [Related]
7. Plaque radiation therapy for malignant melanoma of the iris and ciliary body.
Finger PT
Am J Ophthalmol; 2001 Sep; 132(3):328-35. PubMed ID: 11530044
[TBL] [Abstract][Full Text] [Related]
8. Intraocular collision tumour: case report and literature review.
Coupland SE; Dodson A; Liu H; Du MQ; Angi M; Damato BE
Graefes Arch Clin Exp Ophthalmol; 2013 May; 251(5):1383-8. PubMed ID: 23232651
[TBL] [Abstract][Full Text] [Related]
9. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
[TBL] [Abstract][Full Text] [Related]
10. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
11. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
12. (106)Ruthenium brachytherapy for ciliary recurrence with supraciliary effusion in retinoblastoma.
Chhablani J; Romanzo A; Balmer A; Pica A; Gaillard MC; Cozza R; Moeckli R; Munier FL
Ophthalmic Genet; 2010 Dec; 31(4):190-2. PubMed ID: 20809777
[TBL] [Abstract][Full Text] [Related]
13. Ruthenium plaque radiation for iris and iridociliary melanomas: development of dry eyes?
Razzaq L; de Keizer RJ
Br J Ophthalmol; 2010 Nov; 94(11):1549-50. PubMed ID: 20516146
[No Abstract] [Full Text] [Related]
14. A clinicopathological study of seven globes enucleated after primary radiation therapy for malignant melanoma of the choroid or ciliary body.
Liszauer AD; Brownstein S; Corriveau C; Deschênes J
Can J Ophthalmol; 1990 Dec; 25(7):340-4. PubMed ID: 2090338
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
17. Choroidal melanoma suspect. Conservative treatment and evolution. Case report.
Zemba M; Malciolu RA
Rom J Ophthalmol; 2016; 60(4):264-269. PubMed ID: 29450360
[TBL] [Abstract][Full Text] [Related]
18. Management of ciliary body melanoma with iodine-125 plaque brachytherapy.
Krema H; Simpson ER; Pavlin CJ; Payne D; Vasquez LM; McGowan H
Can J Ophthalmol; 2009 Aug; 44(4):395-400. PubMed ID: 19606159
[TBL] [Abstract][Full Text] [Related]
19. Metastatic disease, eye retention and visual function in conservative treatment of uveal melanoma.
Bornfeld N; Chauvel P; Sauerwein W; Friedrichs W; Tiburtius T; Wessing A; Foerster MH
Front Radiat Ther Oncol; 1997; 30():97-110. PubMed ID: 9205890
[No Abstract] [Full Text] [Related]
20. Multifocal intraocular malignant melanoma: report of two cases and review of the literature.
Dithmar S; Völcker HE; Grossniklaus HE
Ophthalmology; 1999 Jul; 106(7):1345-8. PubMed ID: 10406619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]